New program aims to keep High-Risk cancer gene carriers on track with screenings
NCT ID NCT07565467
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program to help people with inherited cancer gene mutations (like BRCA or Lynch syndrome) stick to recommended cancer screening schedules. Researchers will interview 80 female participants and provide standard care to see if this approach improves adherence and reduces cancer risk. The goal is to lower the chance of developing cancer through better surveillance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to help people with genetic cancer risks stick to screening plans and catch cancer early.
- What could go wrong
- This is an early-stage study with only 80 participants, so results may not apply to everyone. It focuses on adherence, not directly preventing cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACT-GEN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a walking routine alter cancer biomarkers? new trial investigates
- Digital assistant aims to close gaps in hereditary cancer care
- Lynch syndrome patients share colonoscopy struggles in new survey
- Personalized vaccine aims to stop lynch syndrome cancers before they start
- Swiss study aims to find hidden cancer genes in families
- Could lynch syndrome raise your risk of gum disease?